Mubadala investments increase 46% since the beginning of the year

UAE Mubadala Company has achieved a 46% increase in total investments to reach more than $ 11 billion since the beginning of this year until the beginning of December.

According to Arabiya Net, this comes at a time when the new capital invested by all sovereign funds declined during the same period by 36%.

Mubadala has emerged as one of the most active sovereign wealth funds globally this year during the pandemic, establishing a lending partnership with GE Capital, and launching aircraft parts manufacturing. With the help of Airbus and Boeing, it invested in the 364-bed Cleveland Clinic Hospital in Abu Dhabi.

Mubadala, along with Silver Lake, the New York-based private equity firm and Menlo Park, California, invested in a $ 2.25 billion financing round for its Alphabet self-driving car unit in February.

In May, it pledged $ 1.2 billion to buy a stake in the Indian tech and communications giant Geoblatforms - a company backed by Facebook, Silverlake and the Saudi Public Investment Fund, according to Al Bayan newspaper.

In September, Silver Lake announced a $ 2 billion commitment from Mubadala to help it launch a new strategy that allows the private equity firm to invest money over a 25-year period. Much longer than usual for an acquisition fund. Mubadala has also acquired a stake in technology-focused Silver Lake, which has emerged as one of the most active investors during the pandemic.

Mubadala has invested in technology, financial services and retail in an effort to help Abu Dhabi reduce its dependence on oil revenues, according to the Wall Street Journal report.

and swap became the central investor in a new $ 12 billion business venture launched by Apollo to make large loans. While these discussions have been going on since last year, the pandemic has added urgency to the matter, according to informed sources. Mubadala later announced a $ 3.5 billion partnership with Barings to provide smaller loans to mid-sized European companies.

This year Mubadala led or was part of investments in the UK medical software and communications company Envision Pharma Group, BCI Pharma Services of Pennsylvania, and Discovery Evoteq is a pharmaceutical development, based in Germany. And last month, the fund also acquired a stake in the UAE in a company working with Chinese Sinopharm in the third phase of the vaccine trial.